STAB

Statera BioPharma (STAB)

Statera BioPharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:STAB

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/03/15	21 : 00	GlobeNewswire Inc.	Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs	NASDAQ:STAB	Statera BioPharma Inc
2023/03/04	00 : 47	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:STAB	Statera BioPharma Inc
2023/02/27	20 : 08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:STAB	Statera BioPharma Inc
2023/02/15	23 : 10	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:STAB	Statera BioPharma Inc
2023/02/02	06 : 35	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STAB	Statera BioPharma Inc
2023/02/02	06 : 10	Edgar (US Regulatory)	Securities Registration (section 12(g)) (8-a12g)	NASDAQ:STAB	Statera BioPharma Inc
2022/11/18	22 : 04	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:STAB	Statera BioPharma Inc
2022/11/15	20 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STAB	Statera BioPharma Inc
2022/11/15	07 : 53	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:STAB	Statera BioPharma Inc
2022/10/28	06 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STAB	Statera BioPharma Inc
2022/10/21	22 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:STAB	Statera BioPharma Inc
2022/10/18	06 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STAB	Statera BioPharma Inc
2022/10/06	19 : 01	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:STAB	Statera BioPharma Inc
2022/09/23	19 : 02	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:STAB	Statera BioPharma Inc
2022/09/09	19 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STAB	Statera BioPharma Inc
2022/08/26	20 : 49	GlobeNewswire Inc.	Nasdaq Resumes Trading in Statera Biopharma, Inc.	NASDAQ:STAB	Statera BioPharma Inc
2022/08/26	00 : 48	GlobeNewswire Inc.	Nasdaq Halts Statera Biopharma, Inc.	NASDAQ:STAB	Statera BioPharma Inc
2022/08/04	04 : 00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STAB	Statera BioPharma Inc
2022/06/14	20 : 30	GlobeNewswire Inc.	Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting Firm	NASDAQ:STAB	Statera BioPharma Inc
2022/06/07	05 : 53	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STAB	Statera BioPharma Inc
2022/05/28	06 : 55	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STAB	Statera BioPharma Inc
2022/05/24	05 : 05	GlobeNewswire Inc.	Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-Q Filing	NASDAQ:STAB	Statera BioPharma Inc
2022/05/13	20 : 30	GlobeNewswire Inc.	Statera Biopharma and Lay Sciences Inc. Announce Intent to Enter Strategic Partnership to License the Manufacturing Rights to Certain Lay Sciences IgY Products	NASDAQ:STAB	Statera BioPharma Inc
2022/04/28	05 : 10	GlobeNewswire Inc.	Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone	NASDAQ:STAB	Statera BioPharma Inc
2022/04/23	06 : 26	GlobeNewswire Inc.	Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K Filing	NASDAQ:STAB	Statera BioPharma Inc
2022/04/19	05 : 56	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STAB	Statera BioPharma Inc
2022/04/16	06 : 15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STAB	Statera BioPharma Inc
2022/04/14	05 : 05	GlobeNewswire Inc.	Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to Entolimod	NASDAQ:STAB	Statera BioPharma Inc
2022/04/13	22 : 23	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:STAB	Statera BioPharma Inc
2022/04/13	20 : 00	PR Newswire (US)	Coeptis Therapeutics Announces Intent to Acquire TLR5 Agonist Platform, Including Clinical-Stage Asset Entolimod, from Statera Biopharma	NASDAQ:STAB	Statera BioPharma Inc